The remaining studies providing a CBT intervention to psychiatric samples, targeting patients with depression [41] and posttraumatic stress disorder [23,24], showed no significant changes in biomarkers, particularly stress-related biomarkers [24,41] and oxytocin and vasopressin concentrations [23]. This evidence concerns the gene OXT and depressive symptom measurement.